Carol R. Lizak
CIK: 0001785794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Jaguar Health, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 11, 2025JAGX
Jaguar Health, Inc.
Award(A)Direct11.7K shares- - Mar 31, 2025JAGX
Jaguar Health, Inc.
Purchase(P)DirectConvertible Promissory Note
5.4K shares at avg. $30000.00- - Mar 31, 2025JAGX
Jaguar Health, Inc.
Purchase(P)DirectWarrant to Purchase Common Stock
5.4K shares- - Oct 8, 2024JAGX
Jaguar Health, Inc.
Award(A)Direct4.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | Award(A) | 11,740 | - | - | Direct |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | Purchase(P) Convertible Promissory Note | 5,400 | $30000.00 | - | Direct |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | Purchase(P) Warrant to Purchase Common Stock | 5,400 | - | - | Direct |
| Oct 8, 2024 | JAGX Jaguar Health, Inc. | Award(A) | 4,280 | - | $0 | Direct |
1-4 of 4 transactions
About Lizak Carol R.
Lizak Carol R. (SEC CIK 0001785794) files insider reports with the SEC as Chief Financial Officer of Jaguar Health, Inc. (JAGX).
Signal8 holds 3 ownership filings by Lizak Carol R., all Form 4s, filed between Oct 10, 2024 and Dec 15, 2025. Those filings report 4 transactions, from Oct 8, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Lizak Carol R.'s filings is in SAN FRANCISCO, CA.
Recent filings by Lizak Carol R.
Other insiders filing for Jaguar Health, Inc. (JAGX)
- MICEK JOHN, Director
- King Steven R.
- CONTE LISA A
- Wolin Jonathan S.
- Chaturvedi Pravin R, Chief Scientific Officer
- BOCHNOWSKI JAMES J, Director